Acadia Healthcare Company, Inc. (ACHC) Director Reeve B. Waud Sells 1,240,000 Shares

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Director Reeve B. Waud sold 1,240,000 shares of the stock in a transaction dated Monday, July 31st. The stock was sold at an average price of $51.72, for a total value of $64,132,800.00. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

Reeve B. Waud also recently made the following trade(s):

  • On Wednesday, July 5th, Reeve B. Waud sold 50,000 shares of Acadia Healthcare stock. The shares were sold at an average price of $50.04, for a total value of $2,502,000.00.
  • On Thursday, June 22nd, Reeve B. Waud sold 50,000 shares of Acadia Healthcare stock. The shares were sold at an average price of $47.51, for a total value of $2,375,500.00.
  • On Wednesday, June 14th, Reeve B. Waud sold 724,694 shares of Acadia Healthcare stock. The shares were sold at an average price of $45.53, for a total value of $32,995,317.82.
  • On Friday, June 9th, Reeve B. Waud sold 50,000 shares of Acadia Healthcare stock. The shares were sold at an average price of $45.09, for a total value of $2,254,500.00.

Acadia Healthcare Company, Inc. (NASDAQ ACHC) traded down 0.19% on Friday, reaching $46.90. The company had a trading volume of 2,127,576 shares. The firm has a market capitalization of $4.12 billion, a PE ratio of 515.38 and a beta of 1.15. The stock has a 50 day moving average of $50.51 and a 200 day moving average of $45.06. Acadia Healthcare Company, Inc. has a 12 month low of $32.54 and a 12 month high of $54.34.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Thursday, July 27th. The company reported $0.66 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.65 by $0.01. Acadia Healthcare had a return on equity of 8.69% and a net margin of 0.30%. The firm had revenue of $715.90 million for the quarter, compared to analysts’ expectations of $717.38 million. During the same quarter in the prior year, the firm posted $0.73 earnings per share. Acadia Healthcare’s revenue for the quarter was down 5.4% compared to the same quarter last year. On average, analysts anticipate that Acadia Healthcare Company, Inc. will post $2.45 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally published by Rincon Hill News and is owned by of Rincon Hill News. If you are accessing this piece of content on another website, it was illegally copied and republished in violation of US & international copyright & trademark laws. The original version of this piece of content can be viewed at https://rinconhillneighbors.org/2017/08/19/insider-selling-acadia-healthcare-company-inc-achc-director-sells-1240000-shares-of-stock-updated-updated.html.

A number of equities research analysts have issued reports on ACHC shares. Mizuho increased their price target on Acadia Healthcare from $57.00 to $60.00 and gave the company a “buy” rating in a research report on Friday, July 28th. Jefferies Group LLC set a $55.00 price target on Acadia Healthcare and gave the company a “buy” rating in a research report on Thursday, June 1st. BidaskClub raised Acadia Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, July 1st. Zacks Investment Research raised Acadia Healthcare from a “hold” rating to a “buy” rating and set a $53.00 price target on the stock in a research report on Wednesday, June 28th. Finally, Craig Hallum reaffirmed a “buy” rating and issued a $65.00 price target (up previously from $52.00) on shares of Acadia Healthcare in a research report on Monday, July 31st. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the stock. Acadia Healthcare presently has an average rating of “Buy” and a consensus target price of $59.21.

A number of hedge funds have recently made changes to their positions in ACHC. Russell Investments Group Ltd. boosted its stake in shares of Acadia Healthcare by 43.9% in the first quarter. Russell Investments Group Ltd. now owns 221,649 shares of the company’s stock worth $9,664,000 after buying an additional 67,665 shares during the last quarter. First Mercantile Trust Co. boosted its stake in shares of Acadia Healthcare by 49.3% in the first quarter. First Mercantile Trust Co. now owns 10,175 shares of the company’s stock worth $443,000 after buying an additional 3,359 shares during the last quarter. Mesirow Financial Investment Management Equity Management bought a new stake in shares of Acadia Healthcare during the first quarter worth $17,724,000. Nationwide Fund Advisors boosted its stake in shares of Acadia Healthcare by 683.9% in the first quarter. Nationwide Fund Advisors now owns 75,852 shares of the company’s stock worth $3,307,000 after buying an additional 66,176 shares during the last quarter. Finally, Parametrica Management Ltd bought a new stake in shares of Acadia Healthcare during the first quarter worth $291,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Insider Buying and Selling by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with our FREE daily email newsletter.

 

Latest News



Leave a Reply

 
© 2006-2017 Rincon Hill News.